Recent advances in refractory coeliac disease

Histopathology

Volumn 54, Issue 7, 2009, Pages 783-795

  Ho Yen, C ^a,b   Chang, F ^a   Van Der Walt, J ^a   Mitchell, T ^a   Ciclitira, P ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Enteropathy type T cell lymphoma; Gastrointestinal; Histopathology; Refractory coeliac disease; Ulcerative jejunitis

Indexed keywords

AZATHIOPRINE; CLADRIBINE; GLUTEN; PENTOSTATIN; PREDNISOLONE;

ADENOCARCINOMA; CARCINOGENESIS; CELIAC DISEASE; CLINICAL FEATURE; DIET RESTRICTION; DISEASE COURSE; ENTEROPATHY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GLUTEN FREE DIET; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; PATHOGENESIS; PHARYNX CARCINOMA; PRIORITY JOURNAL; REFRACTORY CELIAC DISEASE; REVIEW; SMALL INTESTINE CARCINOMA; T CELL LYMPHOMA; ULCERATIVE JEJUNITIS;

CELIAC DISEASE; DIET, GLUTEN-FREE; ENTERITIS; GASTROINTESTINAL NEOPLASMS; HUMANS; JEJUNAL DISEASES; LYMPHOMA, NON-HODGKIN; LYMPHOMA, T-CELL;

EID: 66949114390     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/j.1365-2559.2008.03112.x     Document Type: Review

References (67)

1. Green PHR, Cellier C. Celiac disease. N. Engl. J. Med. 2007 357 1731 1743.
2. van Heel DA, West J. Recent advances in coeliac disease. Gut 2006 55 1037 1046. (Pubitemid 43962618)
3. Ciclitira PJ, King AL, Fraser JS. AGA technical review on celiac sprue. American Gastroenterological Association. Gastroenterology 2001 120 1526 1540.
4. Cellier C, Cerf-Bensussan N. Treatment of clonal refractory celiac disease or cryptic intraepithelial lymphoma: a long road from bench to bedside. Clin. Gastroenterol. Hepatol. 2006 4 1320 1321. (Pubitemid 44716756)
5. Wahab PJ, Meijer JW, Goerres MS, Mulder CJ. Coeliac disease: changing views on gluten-sensitive enteropathy. Scand. J. Gastroenterol. 2002 236 (Suppl. 60 65. (Pubitemid 35247378)
6. Daum S, Cellier C, Mulder CJ. Refractory coeliac disease. Best Pract. Res. Clin. Gastroenterol. 2005 19 413 424. (Pubitemid 40753762)
7. Koning F. Celiac disease: caught between a rock and a hard place. Gastroenterology 2005 129 1294 1301. (Pubitemid 41447513)
8. McGough N, Cummings JH. Coeliac disease: a diverse clinical syndrome caused by intolerance of wheat, barley and rye. Proc. Nutr. Soc. 2005 64 434 450. (Pubitemid 41705443)
9. Clemente MG, De Virgiliis S, Kang JS et al. Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut 2003 52 218 223. (Pubitemid 36115062)
10. Fasano A, Not T, Wang W et al. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet 2000 355 1518 1519. (Pubitemid 30237361)
11. Green PH, Jabri B. Coeliac disease. Lancet 2003 362 383 391. (Pubitemid 36945070)
12. Rostom A, Murray JA, Kagnoff MF. American Gastroenterological Association (AGA) Institute technical review on the diagnosis and management of celiac disease. Gastroenterology 2006 131 1982 2002.
13. Craig D, Robins G, Howdle PD. Advances in celiac disease. Curr. Opin. Gastroenterol. 2007 23 142 148. (Pubitemid 46192968)
14. Koning F, Schuppan D, Cerf-Bensussan N, Sollid LM. Pathomechanisms in celiac disease. Best Pract. Res. Clin. Gastroenterol. 2005 19 373 387. (Pubitemid 40753759)
15. Cellier C, Delabesse E, Helmer C et al. Refractory sprue, coeliac disease, and enteropathy-associated T-cell lymphoma. French Coeliac Disease Study Group. Lancet 2000 356 203 208.
16. Al-Toma A, Goerres MS, Meijer JW, Peña AS, Crusius JB, Mulder CJ. Human leukocyte antigen-DQ2 homozygosity and the development of refractory celiac disease and enteropathy-associated T-cell lymphoma. Clin. Gastroenterol. Hepatol. 2006 4 315 319. (Pubitemid 43343887)
17. Brousse N, Meijer JW. Malignant complications of coeliac disease. Best Pract. Res. Clin. Gastroenterol. 2005 19 401 412. (Pubitemid 40753761)
18. Di Sabatino A, Ciccocioppo R, Cupelli F et al. Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut 2006 55 469 477.
19. Wolters VM, Verbeek WH, Zhernakova A et al. The MYO9B gene is a strong risk factor for developing refractory celiac disease. Clin. Gastroenterol. Hepatol. 2007 5 1399 1405.
20. De Re V, Simula MP, Caggiari L et al. Proteins specifically hyperexpressed in a coeliac disease patient with aberrant T cells. Clin. Exp. Immunol. 2007 148 402 409. (Pubitemid 46701019)
21. Bernardo D, van Hoogstraten IM, Verbeek WH et al. Decreased circulating iNKT cell numbers in refractory coeliac disease. Clin. Immunol. 2008 126 172 179.
22. Olaussen RW, Løvik A, Tollefsen S et al. Effect of elemental diet on mucosal immunopathology and clinical symptoms in type 1 refractory celiac disease. Clin. Gastroenterol. Hepatol. 2005 3 875 885. (Pubitemid 41219290)
23. Mallant M, Hadithi M, Al-Toma AB et al. Abdominal computed tomography in refractory coeliac disease and enteropathy associated T-cell lymphoma. World J. Gastroenterol. 2007 13 1696 1700. (Pubitemid 46711340)
24. Al-Toma A, Verbeek WH, Hadithi M, von Blomberg BM, Mulder CJ. Survival in refractory coeliac disease and enteropathy-associated T-cell lymphoma: retrospective evaluation of single-centre experience. Gut 2007 56 1373 1378. (Pubitemid 47517830)
25. Marsh MN. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 1992 102 330 354.
26. Mino-Kenudson M, Brown I, Lauwers GY. Histopathological diagnosis of gluten-sensitive enteropathy. Curr. Diagn. Pathol. 2005 11 274 283. (Pubitemid 40968046)
27. Robert ME, Ament ME, Weinstein WM. The histologic spectrum and clinical outcome of refractory and unclassified sprue. Am. J. Surg. Pathol. 2000 24 676 687. (Pubitemid 30253505)
28. Al-Toma A, Verbeek WH, Mulder CJ. Update on the management of refractory coeliac disease. J. Gastrointest. Liver Dis. 2007 16 57 63. (Pubitemid 46548591)
29. Goerres MS, Meijer JW, Wahab PJ et al. Azathioprine and prednisone combination therapy in refractory coeliac disease. Aliment. Pharmacol. Ther. 2003 18 487 494. (Pubitemid 37152289)
30. Cellier C, Patey N, Mauvieux L et al. Abnormal intestinal intraepithelial lymphocytes in refractory sprue. Gastroenterology 1998 114 471 481. (Pubitemid 28141192)
31. Verkarre V, Asnafi V, Lecomte T et al. Refractory coeliac sprue is a diffuse gastrointestinal disease. Gut 2003 52 205 211. (Pubitemid 36115060)
32. Patey-Mariaud De Serre N, Cellier C, Jabri B et al. Distinction between coeliac disease and refractory sprue: a simple immunohistochemical method. Histopathology 2000 37 70 77. (Pubitemid 30496738)
33. de Mascarel A, Belleannée G, Stanislas S et al. Mucosal intraepithelial T-lymphocytes in refractory celiac disease: a neoplastic population with a variable CD8 phenotype. Am. J. Surg. Pathol. 2008 32 744 751. (Pubitemid 351600824)
34. Bagdi E, Diss TC, Munson P, Isaacson PG. Mucosal intra-epithelial lymphocytes in enteropathy-associated T-cell lymphoma, ulcerative jejunitis, and refractory celiac disease constitute a neoplastic population. Blood 1999 94 260 264. (Pubitemid 29300157)
35. Meijer JW, Mulder CJ, Goerres MG, Boot H, Schweizer JJ. Coeliac disease and (extra)intestinal T-cell lymphomas: definition, diagnosis and treatment. Scand. J. Gastroenterol. 2004 241 (Suppl. 78 84. (Pubitemid 40051455)
36. Elsing C, Placke J, Gross-Weege W. Ulcerative jejunoileitis and enteropathy-associated T-cell lymphoma. Eur. J. Gastroenterol. Hepatol. 2005 17 1401 1405. (Pubitemid 41830464)
37. Jewell DP. Ulcerative enteritis. BMJ (Clin. Res. Ed.). 1983 287 1740 1741. (Pubitemid 14248525)
38. Mills PR, Brown IL, Watkinson G. Idiopathic chronic ulcerative enteritis. Report of five cases and review of the literature. QJM 1980 49 133 149. (Pubitemid 11177254)
39. Ashton-Key M, Diss TC, Pan L, Du MQ, Isaacson PG. Molecular analysis of T-cell clonality in ulcerative jejunitis and enteropathy-associated T-cell lymphoma. Am. J. Pathol. 1997 151 493 498. (Pubitemid 27330068)
40. Smedby KE, Akerman M, Hildebrand H, Glimelius B, Ekbom A, Askling J. Malignant lymphomas in coeliac disease: evidence of increased risks for lymphoma types other than enteropathy-type T cell lymphoma. Gut 2005 54 54 59. (Pubitemid 40007218)
41. Catassi C, Bearzi I, Holmes GK. Association of celiac disease and intestinal lymphomas and other cancers. Gastroenterology 2005 4 (Suppl. 1 S79 S86.
42. Rooney N, Dogan A. Gastrointestinal lymphoma. Curr. Diagn. Pathol. 2004 10 69 78. (Pubitemid 38133429)
43. Isaacson P, Wright D, Ralfkiaer E, Jaffe ES. Enteropathy-type T-cell lymphoma. In Jaffe JS, Harris NL, Stein H, Vardiman JW eds. World Health Organisation classification of tumours. Pathology and genetics of tumours of the haematopoietic and lymphoid tissue. Lyon : IARC Press, 2001 208 209.
44. Deleeuw RJ, Zettl A, Klinker E et al. Whole-genome analysis and HLA genotyping of enteropathy-type T-cell lymphoma reveals 2 distinct lymphoma subtypes. Gastroenterology 2007 132 1902 1911. (Pubitemid 46677947)
45. Murray A, Cuevas EC, Jones DB, Wright DH. Study of the immunohistochemistry and T cell clonality of enteropathy-associated T cell lymphoma. Am. J. Pathol. 1995 146 509 519.
46. Howdle PD, Jalal PK, Holmes GK, Houlston RS. Primary small-bowel malignancy in the UK and its association with coeliac disease. QJM 2003 96 345 353. (Pubitemid 36592706)
47. Rampertab SD, Forde KA, Green PH. Small bowel neoplasia in coeliac disease. Gut 2003 52 1211 1214. (Pubitemid 36877438)
48. Holmes GK, Prior P, Lane MR, Pope D, Allan RN. Malignancy in coeliac disease - effect of a gluten free diet. Gut 1989 30 333 338. (Pubitemid 19091159)
49. Askling J, Linet M, Gridley G, Halstensen TS, Ekström K, Ekbom A. Cancer incidence in a population-based cohort of individuals hospitalised with celiac disease or dermatitis herpetiformis. Gastroenterology 2002 123 1428 1435. (Pubitemid 35231641)
50. Abdulkarim AS, Burgart LJ, See J, Murray JA. Etiology of nonresponsive celiac disease: results of a systematic approach. Am. J. Gastroenterol. 2002 97 2016 2021. (Pubitemid 34912612)
51. Chang F, Mahadeva U, Deere H. Pathological and clinical significance of increased intraepithelial lymphocytes (IELs) in small bowel mucosa. APMIS 2005 113 385 399. (Pubitemid 40961720)
52. Hayat M, Cairns A, Dixon MF, O'Mahony S. Quantitation of intraepithelial lymphocytes in human duodenum: what is normal? J. Clin. Pathol. 2002 55 393 394. (Pubitemid 34494182)
53. Veress B, Franzén L, Bodin L, Borch K. Duodenal intraepithelial lymphocyte-count revisited. Scand. J. Gastroenterol. 2004 39 138 144. (Pubitemid 38258337)
54. Goldstein NS, Underhill J. Morphologic features suggestive of gluten sensitivity in architecturally normal duodenal biopsy specimens. Am. J. Clin. Pathol. 2001 116 63 71. (Pubitemid 32601128)
55. Goldstein NS. Proximal small-bowel mucosal villous intraepithelial lymphocytes. Histopathology 2004 44 199 205. (Pubitemid 38406611)
56. Mino M, Lauwers GY. Role of lymphocytic immunophenotyping in the diagnosis of gluten-sensitive enteropathy with preserved villous architecture. Am. J. Surg. Pathol. 2003 27 1237 1242. (Pubitemid 37040586)
57. Brown I, Mino-Kenudson M, Deshpande V, Lauwers GY. Intraepithelial lymphocytosis in architecturally preserved proximal small intestinal mucosa: an increasing diagnostic problem with a wide differential diagnosis. Arch. Pathol. Lab. Med. 2006 130 1020 1025. (Pubitemid 44061433)
58. Nahon S, Patey-Mariaud De Serre N, Lejeune O et al. Duodenal intraepithelial lymphocytosis during Helicobacter pylori infection is reduced by antibiotic treatment. Histopathology 2006 48 417 423.
59. Memeo L, Jhang J, Hibshoosh H, Green PH, Rotterdam H, Bhagat G. Duodenal intraepithelial lymphocytosis with normal villous architecture: common occurrence in H. pylori gastritis. Mod. Pathol. 2005 18 1134 1144. (Pubitemid 41224506)
60. Leffler DA, Dennis M, Hyett B, Kelly E, Schuppan D, Kelly CP. Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin. Gastroenterol. Hepatol. 2007 5 445 450. (Pubitemid 46575362)
61. Antonioli DA. Celiac disease: a progress report. Mod. Pathol. 2003 16 342 346. (Pubitemid 36443983)
62. Farstad IN, Johansen FE, Vlatkovic L et al. Heterogeneity of intraepithelial lymphocytes in refractory sprue: potential implications of CD30 expression. Gut 2002 51 372 378. (Pubitemid 34907705)
63. Chaudhary R, Ghosh S. Infliximab in refractory coeliac disease. Eur. J. Gastroenterol. Hepatol. 2005 17 603 604. (Pubitemid 40733805)
64. Dray X, Joly F, Lavergne-Slove A et al. A severe but reversible refractory sprue. Gut 2006 55 1210 1211. (Pubitemid 44085696)
65. Al-Toma A, Goerres MS, Meijer JW et al. Cladribine therapy in refractory celiac disease with aberrant T cells. Clin. Gastroenterol. Hepatol. 2006 4 1322 1327 quiz 1300. (Pubitemid 44716738)
66. Hadithi M, Mallant M, Oudejans J, van Waesberghe JH, Mulder CJ, Comans EF. 18F-FDG PET versus CT for the detection of enteropathy-associated T-cell lymphoma in refractory celiac disease. J. Nucl. Med. 2006 47 1622 1627. (Pubitemid 47545027)
67. Schuppan D, Kelly CP, Krauss N. Monitoring non-responsive patients with celiac disease. Gastrointest. Endosc. Clin. N. Am. 2006 16 593 603. (Pubitemid 44108677)